Dr. Luis J. Haddock, MD

Dr. Haddock practices at Bascom Palmer Eye Institute in Miami, Florida.

Dr. Haddock's NPI, 1073769717, was assigned on August 13, 2008. Dr. Haddock graduated from University of Puerto Rico, Medical Sciences Campus in 2008. Dr. Haddock holds Florida license ME120731.

Dr. Haddock's primary practice is Bascom Palmer Eye Institute, at 900 NW 17th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (239) 659-3937.

Dr. Haddock's primary practice is Bascom Palmer Eye Institute in Miami, Florida. Dr. Haddock is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haddock practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Haddock's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Haddock is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Haddock's licenses on file in 3 states: Florida, Puerto Rico and Massachusetts.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Haddock treats.

CMS data shows 30,149 Medicare services from Dr. Haddock across 19 procedure codes in 2024, for 1,498 Medicare patients. Medicare paid $2,186,215 for them. Every service was in an office.

CMS counts 1,498 Medicare patients who saw Dr. Haddock in 2024. The largest group is 75 to 84, with 591 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Haddock's median patient age at 73, with 57% women.

In 2024, Dr. Haddock wrote 745 Medicare Part D claims for 196 patients. 59% of them were for generic drugs. CMS names the drug for 658 of them, across 11 drugs with 11 or more claims each, at $32,683 in total drug cost. In 2023, CMS named 468 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Haddock for performance year 2024, reported as part of a group. Dr. Haddock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haddock as offering telehealth. CMS counts 36 procedures of cataract surgery by Dr. Haddock, more than 57% of the clinicians it reports for that procedure.

Dmand AI links 31 papers to Dr. Haddock, published from 2012 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Retinal Detachment, Angiogenesis Inhibitors and Intravitreal Injections. Dr. Haddock has published most often in Ophthalmol Retina. Dr. Haddock's most frequent co-authors are Jayanth Srinivasan-Kasi Sridhar, MD, Jorge A. Fortun, MD and Nicolas A. Yannuzzi, MD.

Dmand AI links Dr. Haddock to 1 clinical trial. Open Payments lists research payments to Dr. Haddock that name 1 trial.

CMS Open Payments shows 223 general payments to Dr. Haddock from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Alimera Sciences, Inc. paid the most, $18,088. It also lists 3 research payments totaling $657 in 2016, naming 1 clinical trial.

Dr. Haddock graduated from University of Puerto Rico, Medical Sciences Campus in 2008.

Dr. Haddock is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.